Enveric Biosciences, Inc.

Analysis for Ticker: ENVB

Enveric Biosciences Inc claims to be a biotechnology company using artificial intelligence platforms called Psybrary and PsyAI to discover drugs for brain disorders like anxiety and depression. The business is actually a machine designed to burn investor cash while producing exactly zero dollars in revenue. Since they started they have managed to lose a staggering 114,8$ million. Imagine you gave them 100,00$ at the end of 2022 to help find cures. By the end of 2025 your contribution was worth only 0,97$. This is a disaster because the company is not growing by selling medicine but is instead surviving by selling tiny pieces of itself over and over again until the original pieces are worth almost nothing. The destruction began in earnest on 29/01/2025 when the company used a trick called a reverse stock split to combine every fifteen shares into one single share. By 09/04/2025 they signed a contract with a broker named H.C. Wainwright and Company to start selling new shares into the market for a 3,0% fee. In 06/2025 they only had 2,8$ million left in the bank so they begged big investors to buy shares at a massive discount of 0,915$. For this tiny amount they handed over 4,8 million new Series C and Series D contracts to the funds and paid 12.500$ to a group called Kingsdale Advisors just to convince the public to vote for this plan.